Strong FFO Growth and Earnings Execution
Normalized FFO per share of $3.48 for full-year 2025, up 9% year-over-year and at the high end of guidance; fourth-quarter normalized FFO per share grew ~10% year-over-year. 2026 normalized FFO per share guidance of $3.78–$3.88 (midpoint $3.83), representing ~8% year-over-year growth on a comparable basis.
Robust SHOP Operating Performance
Same-store SHOP cash NOI grew 15% (fourth consecutive year of double-digit SHOP NOI growth). Q4 SHOP revenue +8%+, occupancy +300 bps YoY (U.S. +370 bps), RevPOR +4.7% in Q4, and NOI +15.4% YoY (U.S. +18%). Margin expanded ~180 bps to >28% with ~50% incremental margin in Q4 and management expects 13%–17% same-store SHOP NOI growth in 2026 (midpoint 15%) supported by 270 bps occupancy improvement and ~5% RevPOR growth.
Scale, Portfolio Composition and Resident Outcomes
Enterprise value exceeded $50 billion; ownership of over 83,000 SHOP units with SHOP representing ~53% of company NOI. Documented strong resident experience metrics and operator recognitions (e.g., improved Net Promoter Scores at Atria, Le Groupe Maurice ranked leading brand in Quebec, Discovery #1 JD Power ranking).
Active, Accretive Investment Activity
Closed $2.5 billion of high-quality senior housing acquisitions in 2025 and over $800 million closed year-to-date in 2026; cumulative senior housing acquisitions of ~$4.8 billion in a little over a year. 2026 investment guidance of $2.5 billion focused on senior housing with high confidence in execution.
Strong Capital Markets Execution
Raised over $7 billion of capital since the start of 2025 (nearly $4 billion in bank, bonds and mortgage debt and ~$3.2 billion of equity issuance). Company reports pro forma leverage approaching ~5x and improved leverage to 5.2x in Q4 (best since 2012).
Dividend Increase and Shareholder Returns
Board approved an 8% increase in the quarterly dividend; Ventas delivered total shareholder returns of 35% in 2025, significantly outperforming industry benchmarks and the S&P 500 for the year.
OMAR (Outpatient Medical & Research) Resilience
OMAR same-store cash NOI grew nearly 4% for the quarter with outpatient medical same-store NOI +4.5% and occupancy in outpatient medical near 91% (six consecutive quarters of year-over-year occupancy growth). Research portfolio showed modest improvement (same-store NOI +30 bps supported by university tenant occupancy gains).